Sexuality Research and Social Policy

, Volume 15, Issue 3, pp 283–289 | Cite as

HIV Pre-Exposure Prophylaxis (PrEP) Is Coming to Europe, but Are Gay Men Ready to Accept It? Qualitative Findings from Berlin, Germany

  • Christian GrovEmail author
  • Navin Kumar


In 2016, the European Medicines Agency approved the marketing of Truvada for use as pre-exposure prophylaxis (PrEP) in European Union (EU) member states. As individual countries throughout the EU make decisions about whether to adopt PrEP and fund it via governmental insurance, it is vital to understand key populations’ knowledge of and attitudes toward PrEP. In 2015, 20 gay men completed face-to-face audio-recorded interviews, describing their knowledge of and attitudes toward PrEP (mean age 35.9; 35% HIV-positive, 65% HIV-negative). We found that in spite of PrEP not yet having been approved for marketing in Germany, all but one of the participants were aware of PrEP and knew the difference between PrEP and post-exposure prophylaxis (PEP; which is approved for use in Germany). By and large, attitudes were favorable about PrEP, especially among HIV-negative participants. Next, there appeared to be an already high demand for PrEP with several participants going to great lengths to gain access to PrEP; two described intentions to obtain PEP for use as PrEP, one was obtaining PrEP via another country (where it was legal), and a fourth participant was discretely distributing PrEP out of his home. Our findings appear to validate anecdotal evidence suggesting high demand for PrEP and that some are already finding ways to obtain it without governmental approval. Our findings suggest that participants were prepared to see the rollout of PrEP in Berlin, pending its approval.


Pre-exposure prophylaxis (PrEP) Gay men Men who have sex with men Barebacking HIV Berlin Germany 



This study was supported in part by the Tow Fellowship. A special thanks to the research participants who gave their time and shared their stories, Philip Gussmann, and the research team at the Hunter College Center for HIV/AIDS Educational Studies and Training.

Compliance with Ethical Standards

Conflicts of Interest

The authors declare that they have no conflicts of interest.

Research Involving Human Participants

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Informed Consent

Informed consent was obtained from all individual participants included in the study. Consent documents were available in English and German.


This study was supported in part by the Tow Fellowship.


  1. Badia, X., Webb, S. M., Prieto, L., & Lara, N. (2004). Acromegaly quality of life questionnaire (AcroQoL). Health Qual Life Outcomes, 2(1), 13.CrossRefPubMedPubMedCentralGoogle Scholar
  2. Barnett, L. (2013. Germany a “sex tourism hotspot”. Retrieved from
  3. Bauermeister, J. A., Meanley, S., Pingel, E., Soler, J. H., & Harper, G. W. (2013). PrEP awareness and perceived barriers among single young men who have sex with men in the United States. Curr HIV Res, 11(7), 520.CrossRefPubMedPubMedCentralGoogle Scholar
  4. Beachy, R. (2015). Gay Berlin: Birthplace of a modern identity. New York: Vintage.Google Scholar
  5. CDC. (2014). Pre-exposure prophylaxis for the prevention of HIV infection in the United States—2014: A clinical practice guideline. Retrieved from
  6. Cohen, S. E., Vittinghoff, E., Bacon, O., Doblecki-Lewis, S., Postle, B. S., Feaster, D. J., & Estrada, Y. (2015). High interest in pre-exposure prophylaxis among men who have sex with men at risk for HIV-infection: Baseline data from the US PrEP demonstration project. Journal of acquired immune deficiency syndromes (1999), 68(4), 439.CrossRefGoogle Scholar
  7. Deimel, D., Stöver, H., Hößelbarth, S., Dichtl, A., Graf, N., & Gebhardt, V. (2016). Drug use and health behaviour among German men who have sex with men: Results of a qualitative, multi-centre study. Harm Reduction Journal, 13(1), 36.CrossRefPubMedPubMedCentralGoogle Scholar
  8. Edsall, N. C. (2006). Toward stonewall: Homosexuality and society in the modern western world. Charlottesville: University of Virginia Press.Google Scholar
  9. European Medicines Agency. (2016). European Medicines Agency—What we do—Authorization of medicines. Retrieved from
  10. Gilead. (2012). U.S. Food and Drug Administration approves Gilead’s Truvada® for reducing the risk of acquiring HIV | Gilead. Retrieved from
  11. Gilead. (2016). European Medicines Agency validates Gilead’s type II variation application for Truvada® for reducing the risk of sexually acquired HIV. Retrieved from
  12. Given, L. M. (2008). The SAGE encyclopedia of qualitative research methods. Thousand Oaks, CA: Sage Publications.CrossRefGoogle Scholar
  13. Golub, S. A., Gamarel, K. E., Rendina, H. J., Surace, A., & Lelutiu-Weinberger, C. L. (2013). From efficacy to effectiveness: Facilitators and barriers to PrEP acceptability and motivations for adherence among MSM and transgender women in New York City. AIDS Patient Care STDs, 27(4), 248–254.CrossRefPubMedPubMedCentralGoogle Scholar
  14. Grov, C. (2017). Gay men’s perspectives on HIV prevention and treatment in Berlin, Germany: Lessons for policy and prevention. International Journal of Sexual Health. doi: 10.1080/19317611.2016.1247758.Google Scholar
  15. Grov, C., Rendina, H. J., Whitfield, T. H. F., Ventuneac, A., & Parsons, J. T. (2016). Changes in familiarity with and willingness to take PrEP in a longitudinal study of highly sexually active gay and bisexual men. LGBT Health, 3(4), 252–257. doi: 10.1089/lgbt.2015.0123.CrossRefPubMedPubMedCentralGoogle Scholar
  16. Grov, C., Restar, A., Gussman, P., Schlemmer, K., & Rodriguez-Diaz, C. P. (2014). Provider’s perspectives on the best practices for HIV prevention for men who have sex with men in Berlin, Germany: Lessons for policy and prevention. AIDS Educ Prev, 26, 485–499.CrossRefPubMedGoogle Scholar
  17. Guest, G., Bunce, A., & Johnson, L. (2006). How many interviews are enough? Field Methods, 18(1), 59–82.CrossRefGoogle Scholar
  18. Jaspal, R., & Daramilas, C. (2016). Perceptions of pre-exposure prophylaxis (PrEP) among HIV-negative and HIV-positive men who have sex with men (MSM). Cogent Medicine (just-accepted), 1256850.Google Scholar
  19. Kramer, S. C., Drewes, J., Kruspe, M., & Marcus, U. (2015). Factors associated with sexual risk behaviors with non-steady partners and lack of recent HIV testing among German men who have sex with men in steady relationships: Results from a cross-sectional internet survey. BMC Public Health, 15(1), 702.CrossRefPubMedPubMedCentralGoogle Scholar
  20. Liu, A., Cohen, S., Follansbee, S., Cohan, D., Weber, S., Sachdev, D., & Buchbinder, S. (2014). Early experiences implementing pre-exposure prophylaxis (PrEP) for HIV prevention in San Francisco. PLoS Med, 11(3), e1001613.CrossRefPubMedPubMedCentralGoogle Scholar
  21. Lonely Planet. (2012. Top gay-friendly destinations. Retrieved from
  22. Marcus, U., Kollan, C., Bremer, V., & Hamouda, O. (2005). Relation between the HIV and the re-emerging syphilis epidemic among MSM in Germany: An analysis based on anonymous surveillance data. Sex Transm Infect, 81(6), 456–457.CrossRefPubMedPubMedCentralGoogle Scholar
  23. Marcus, U., Schmidt, A. J., Kollan, C., & Hamouda, O. (2009). The denominator problem: Estimating MSM-specific incidence of sexually transmitted infections and prevalence of HIV using population sizes of MSM derived from Internet surveys. BMC Public Health, 9(1), 181.CrossRefPubMedPubMedCentralGoogle Scholar
  24. Marcus, U., Voss, L., Kollan, C., & Hamouda, O. (2006). HIV incidence increasing in MSM in Germany: Factors influencing infection dynamics. Euro surveillance: bulletin europeen sur les maladies transmissibles= European communicable disease bulletin, 11(9), 157–160.Google Scholar
  25. McCall, H., Adams, N., Mason, D., & Willis, J. (2015). What is chemsex and why does it matter?Google Scholar
  26. Miles, M. B., & Huberman, M. (1994). Qualitative data analysis: An expanded sourcebook. Thousand Oaks: Sage Publications.Google Scholar
  27. (2010). Two million citizens speak at least two languages—Wirtschaft (Print)—Berliner Morgenpost. Retrieved from
  28. Morse, J. M. (1995). The significance of saturation. Qual Health Res, 5(2), 147–149.CrossRefGoogle Scholar
  29. Neuendorf, K. A. (2002). The content analysis guidebook. Thousand Oaks: Sage.Google Scholar
  30. Parsons, J. T., Rendina, H. J., Lassiter, J. M., Whitfield, T. H. F., Starks, T. J., & Grov, C. (2017). Uptake of HIV pre-exposure prophylaxis (PrEP) in a national sample of gay and bisexual men in the United States: The motivational PrEP cascade. Journal of AIDS.Google Scholar
  31. Patton, M. Q. (1990). Qualitative evaluation research (2nd ed.). Newbury Park: Sage Publications, Inc..Google Scholar
  32. PrEP in Europe Initiative. (2016). PrEP access in Europe. Retrieved from
  33. PrEPWatch. (2015). France Retrieved from
  34. PrEPWatch. (2016). Country updates. Retrieved from
  35. Robert Koch Institut. (2013). Epidemiologisches Bulletin: HIV-infektionen und AIDS-Erkankungen in Deutschland. 24.Google Scholar
  36. Robert Koch Institut. (2014). Epidemiologisches Bulletin: Aktuelle Daten und Informationen zu Infektionskrankheiten und Public Health. Retrieved from
  37. Rodgers, T. (2014). Berghain: The secretive, sex-fueled world of techno’s coolest club. Retrieved from
  38. Saldaña, J. (2013). The coding manual for qualitative research (2nd ed.). Thousand Oaks: Sage.Google Scholar
  39. Singer, E., Von Thurn, D. R., & Miller, E. R. (1995). Confidentiality assurances and response a quantitative review of the experimental literature. Public Opinion Quarterly, 59(1), 66–77.CrossRefGoogle Scholar
  40. Spiegel Online. (2015). Testing the limits: How many refugees can Germany handle? Retrieved from
  41. Tangmunkongvorakul, A., Chariyalertsak, S., Amico, K. R., Saokhieo, P., Wannalak, V., Sangangamsakun, T., et al. (2013). Facilitators and barriers to medication adherence in an HIV prevention study among men who have sex with men in the iPrEx study in Chiang Mai, Thailand. AIDS Care, 25(8), 961–967.CrossRefPubMedGoogle Scholar
  42. Whisnant, C. (2008). Gay German history: Future directions? J Hist Sex, 17(1), 1–10.Google Scholar
  43. WHO. (2014). Consolidated guidelines on HIV prevention, diagnosis, treatment and care for key populations. Retrieved from
  44. WHO. (2015). WHO expands recommendation on oral pre-exposure prophylaxis of HIV infection (PrEP): Policy brief. Retrieved from
  45. Young, I., & McDaid, L. (2014). How acceptable are antiretrovirals for the prevention of sexually transmitted HIV?: A review of research on the acceptability of oral pre-exposure prophylaxis and treatment as prevention. AIDS Behav, 18(2), 195–216.CrossRefPubMedGoogle Scholar
  46. Zarwell, M., Payne, N., & Robinson, W. T. (2015). Usage and perceptions of PrEP among men who have sex with men (MSM) in New Orleans, 2014. Paper presented at the 143rd APHA Annual Meeting and Exposition, Chicago.Google Scholar

Copyright information

© Springer Science+Business Media New York 2017

Authors and Affiliations

  1. 1.Department of Community Health and Social SciencesCUNY Graduate School of Public Health and Health PolicyNew YorkUSA
  2. 2.Doctoral Program in SociologyYale UniversityNew HavenUSA

Personalised recommendations